The Latest Breaking News from Corteva

Corteva shows rising price performance, earning an upgrade to its IBD Relative Strength Rating

Share buybacks will boost these stocks' prices in 2025 and beyond. Robust cash flow and healthy balance sheets are two common factors.

Equity traders often overlook seasonality (market cycles). Commodity traders are well aware of the significance that seasonal patterns play. Here is an opportunity for equity traders to capitalize on a seasonal pattern in the corn market that has helped to create an astonishing 130% 5-year return for this company. As…

Corteva is expected to release its fiscal third-quarter earnings next month, and analysts project a double-digit increase in loss.

Explore why traditional value investing often falls short and how catalysts can transform undervalued stocks into lucrative investments.

Corteva has recently outperformed the S&P 500, and Wall Street analysts remain moderately optimistic about the stock’s prospects.

Corteva has lagged the broader market over the past year, and analysts are moderately optimistic about the stock’s prospects.

Corteva is expected to release its second-quarter earnings later this month, and analysts project a double-digit earnings growth.

The European Commission launched a proposal in July 2023 to deregulate a large number of plants manufactured using new genetic techniques.